155 results about "Meiosis" patented technology

In an in vitro fertilization method, a woman is treated with a hypothalamic hormone and/or a pituitary hormone or an agonist or antagonist thereof or an active derivative thereof for a short period of time and, thereafter, using in vitro oocyte maturation egg or eggs are retrieved from the woman and are maturated using a meiosis activating compound.

In vitro fertilization can be improved by adding a meiosis activating compound.

The invention provides methods of modifying the level of expression or functional activity of factors such as enzymes or other catalytic proteins or structural proteins, alone or in concert, to modify the frequency of meiotic homologous recombination involving the exchange of genetic information between non-sister chromatids from homologous maternal and paternal chromosomes. The steps at which modulation may occur include: homologous chromosome pairing, double-strand break formation; resection; strand invasion; branch migration; and resolution. Methods of plant and animal breeding are also provided that utilize the modulation of meiotic homologous recombination.

The present invention provides polyploid rice selectively breeding and identifying method with polyploid meiosis stability (PMeS) gene. The rice selectively breeding process includes: selecting parents; hybridization or complex hybridization; back crossing; doubling chromosome; identifying polyploid; selecting bearing property; observing meiosis behavior; self-crossing to form stable line; and identifying high bearing property. The identifying indexes include: polyploid line of Asia cultivated indica type rice or japonica rice; bearing rate not lower than 65 %; normal meiosis behavior; normal pollen shape and physiological activity and normal dyed pollution with 0.1 5 I-KI not lower than 95 %; bearing rate of hybrid of PMeS polyploid rice and other polyploid rice variety over 70 % and that of PMeS polyploid rice and wild rice variety over 65 %. The present invention solves the problem of low bearing rate of polyploid rice and may be used in breeding polyploid rice variety.

The present invention relates to a method of controlled ovarian hyperstimulation in a mammalian female, said method comprising administration to said female of a substance having follicle stimulating hormone activity (FSH substance) in an amount effective to stimulate follicular development and of anti-P in an effective amount to prevent a premature endogenous LH-surge, followed by the administration of a meiosis and luteinisation inducing substance (ML substance) in an amount effective to stimulate resumption of meiosis and luteinisation, and of a progestogen and/or a precursor thereof in an amount effective to prevent or suppress symptoms of progesterone antagonism and/or deficiency, wherein the progestogen and/or the precursor thereof is administered within 24 hours of the first administration of the ML substance. The present invention also relates to a pharmaceutical kit for use in a method of controlled ovarian hyperstimulation in mammalian females, said kit comprising a parenteral dosage unit containing a FSH substance, a parenteral or oral dosage unit containing an anti-P and a parenteral or oral dosage unit containing a progestogen and/or a precursor thereof.

One aspect of the present invention is concerned with a method of controlled ovarian hyperstimulation in a mammalian female, said method comprising the co-administration to said female of a substance having follicle stimulating hormone activity (FSH substance) in an amount effective to stimulate multiple follicular development;—gonadotropin releasing hormone (GnRH) antagonist in an amount equivalent to a daily subcutaneous dose of at least 0.5 mg ganirelix to prevent a premature LH-surge; and—a LH substance in an amount effective to prevent or suppress symptoms of luteinising hormone (LH) deficiency resulting from the administration of the GnRH antagonist; followed by administering a meiosis and luteinisation inducing substance (ML substance) in an amount effective to stimulate resumption of meiosis and luteinisation, and wherein the LH substance is not obtained from the urine of human females. Another aspect of the to invention relates to a pharmaceutical kit for use in a method of controlled hyperstimulation, which kit comprises:—at least one parenteral or oral dosage unit containing one or more FSH substances in an amount equivalent to a subcutaneous dose of 50-1500 I.U. FSH;—at least one parenteral dosage unit containing one or more GnRH antagonists in an amount equivalent to a subcutaneous dose of 0.5-25 mg ganirelix;—at least one parenteral dosage unit containing one or more LH substances in an amount equivalent to a subcutaneous dose of 50-3000 I.U. recombinant LH; wherein the LH substance is not obtained from the urine of human females.

The invention relates to the field of meiotic homologous recombination in plants. Provided are transgenic plants, cytological assays and MLH1 protein and nucleic acid sequences, as well anti-MLH1 antibodies, anti-SMC1, anti-SMC3 and anti-CENP-C antibodies.

Murine and human Suv39h2 polypeptide and DNA molecules encoding them. Suv39h2 is a novel member of the Suv3-9 gene family. Suv39h2 is a novel component of meiotic higher order chromatin. It has histone methyltransferase activity and is required, in combination with Suv39h1, for male gametogenesis. Suv39h2 can be used in screening methods to identify modulators of its methyltransferase activity, which are useful in cancer therapy and for male contraception.

The invention describes human genes involved in cell cycle progression, including mitosis and meiosis. The invention also relates to the use of these “cell cycle progression” genes and proteins in the modulation of cell cycle progression in cells and methods for identifying modulators of these genes or proteins and hence modulators of mitosis and meiosis.

The invention discloses a human immaturity ovum external mature culture method, which comprises: preparing for human external mature culture liquid, adding self-body mature follicle liquid to prepare for the culture liquid A, positioning the immaturity ovum of the first inter middle phase in the micro drop of the culture liquid A, adding separated and purified self-body ovum particle cell deposition in the culture liquid A to float into the culture liquid B with self-body ovum particle cell density 1-5*105/ml, adding the immaturity ovum of the first inter front phase in the micro drop of the culture liquid B.

Clonal embryos or seeds produced by conversion of apomeiotic gametes into clonal embryos or seeds. Clonal embryos or seeds are produced by crossing a MiMe plant, as either a female or male, with an appropriate plant which induces genome elimination (genome eliminator, GE). MiMe plants are those in which meiosis is totally replaced by mitosis. In specific embodiments MiMe plants are MiMe-1 plants or MIME-2 plants. In specific embodiments MiMe plants are mutant plants. In a more specific embodiment, the genome eliminator is a haploid inducer exhibiting directed genome elimination of its own genome.

The invention relates to wheat male sterility genes WMS and an application of an anther specific promoter thereof. The anther transcriptomes of the wheat near-isogenic line 'Lu wheat 15' and 'Lu wheat 15+Ms2' ('Lu wheat 15Ms2' for short) during the meiosis early period are compared by means of the RNA sequencing technique, and the genes WMS only expressed in 'Lu wheat 15Ms2' anther tissue are found. The full-length cDNA sequence of the WMS genes is shown in SEQ ID NO:1. The amino acid sequence of WMS gene coding protein, namely WMS protein, is shown in SEQ ID NO:2. The WMS gene promoter has the activity of triggering anther tissue specificities, the fertility of the stamen of wheat and slender false brome grass can be changed by manually operating the WMS genes. Therefore, the wheat male sterility genes WMS and the application of the anther specific promoter thereof can be used for realizing anther specificity expression of target genes, establishment of plant male sterility, establishment of a plant recurrent selection system and development of the plant hybrid seed production technique.

An amphidiploid aquatic animal according to the present invention has genomes AB of different species and carries fertile XXXY sex chromosomes. Among a large number of aquatic animals of the first filial generation kept in a closed system, a nonreductive sperm of a male and a nonreductive egg of a female are selected. Then the nonreductive egg is fertilized with the nonreductive sperm to create an amphidiploid aquatic animal having fertile XXXY sex chromosomes. Since this amphidiploid has the XXXY sex chromosomes, it can be crossed with an egg A_XB_X of an F1 hybrid that produces nonreductive eggs, thus ensuring a stable creation of amphidiploids in the subsequent generations by natural crossbreeding. In the meiotic division, one set of the chromosomes of each species is assuredly distributed to each gamete. Therefore, the trait of the first generation (F1) will be perpetually maintained. Since no genetic separation takes place, two sets of the genomes of different species are always inherited to every individual. Therefore, inbreeding depression will not take effect even if relative mating is repeated.

The invention relates to an immature oocyte in vitro maturation promoting culture medium and application thereof. The immature oocyte in vitro maturation promoting culture medium is screened out through research on effects of different additives on immature oocytes and prepared by adding 20-100 mu M of BAPTA-AM in normal oocyte in vitro maturation culture solution. The immature oocyte in vitro maturation promoting culture medium is safe and free to side and toxic effects, enables meiosis of the immature oocytes, particularly those in level 3 cumulus-oocyte complexes, improves the in vitro development of the oocytes, promotes maturation, improves the cleavage rate and the blastula development rate after the mature oocytes are parthenogenetically-activated and further improves embryo quality. Application of the immature oocyte in vitro maturation promoting culture medium provides favorable support for the technology of in vitro propagation of animal embryos.

The invention provides a cultivation method for carassius auratus gynogenesis fries. The method comprises the steps of selecting sexually mature diploid carassius auratus parents and collecting sperm and ovums; performing ultraviolet irradiation on Hanks liquid-diluted sperms to inactivate genetic materials thereof; performing artificial insemination on the inactivated sperms and the ovums; restraining the discharge of second polar bodies of meiosis by using a cold shock method to double genomes of the ovums and thus to cultivate viable carassius auratus gynogenesis diploid fries. Microsatellite marker identification proves that the genetic materials of all the gynogenesis fries are from the female parent; morphological measurement indicates part of the gynogenesis fries has obvious early growth dominance. The method has the advantages of simple operation, high efficiency, stability and high practicality.

The invention belongs to the technical field of genetic engineering and particularly relates to a function and application of an arabidopsis thaliana POL2A gene in reduction division recombination. The application comprises the following steps of using sequence characteristics of coding POL2A protein and the authentication of the new function of the gene in reduction division, i.e. using a fluorescent label site system to analyze the influence of POL2A to reduction division recombination frequency and distribution, and providing a fluorescent label-containing genetic material; providing the function of the gene of analyzing how complete mutation of the gene causes embryo death in reduction division, and providing the technology of a series of cell biology and the like. The important function of POL2A in reduction division recombination is proved in an eukaryote for the first time; the function is used, the modern biotechnology method is used, and the recombination frequency of a generic material in a reduction division process is controlled, so that aggregation of excellent characters is quickened, separation of the excellent characters in a hybrid offspring is delayed, and the aim of propelling and improving breeding study level is fulfilled.

A teaching model for demonstrating cell division is composed of a flexible transparent chromosome magnetic model, a homologous chromosome cross exchange model, and a cell division telescopic rope model. The flexible transparent chromosome magnetic model is used for demonstrating the behavior relationship of chromosome, chromatid, DNA and gene in the processes of mitosis and meiosis, demonstrating the relationship between meiosis and the basic genetic laws and demonstrating the chromosome number and structure variation. The homologous chromosome cross exchange model is used for demonstrating cross exchange in the tetrad stage of meiosis. The cell division telescopic rope model is used for demonstrating depression and hanging division in the middle of cytomembrane in the process of animal cell division and demonstrating a dynamic change process in which a cell plate is extended to a cell wall and one cell is divided into two cells in the late stage of plant cell separation.

The invention relates to cytochemistry and cellular immunology, which are particularly used for observing a marine bivalve meiosis device through immunofluorescence microscopy. A sample can be observed after pre-treatment of fixing and the like, dyeing and flaking. The sample is fixed by phosphate buffered saline (PBS) of paraformaldehyde at a mass percentage concentration of 2 to 6 percent; then,permeabilization treatment and sealing treatment are performed sequentially; immunofluorescence dyeing is performed on sample spindle bodies, and fluorescence dyeing is performed on chromosomes withthe phosphate buffered saline containing propidium iodide of which the concentration is 5 to 20 mg of per liter; and the sample is flaked after dyeing for observation through fluorescence microscopy.The cytological immunofluorescence observation method is suitable for observing the spindle bodies and the chromosomes of the marine bivalve meiosis device synchronously, has the advantages of simpleand direct operation, high definition and high study efficiency, and is a qualitative, positioning and quantitative cytological immunofluorescence observation method which inosculates forms and functions.

The invention relates to an oryza sativa male sterility gene OsFIGNL1 (oryza sativa Fidgetin-like 1) and an application thereof. The nucleotide sequence of the gene OsFIGNL1 is shown as SEQ ID NO:1. One function lost mutant of OsFIGNL1 is obtained through <60>Co-gamma mutagenesis, and the mutant in a field planting environment shows the following characteristics: vegetative growth of plants are normal, male plants are sterile, pollen is 100% typically abortive, and development of female gametes is not affected. Meiosis squashing operation shows that chromosome behaviors are severely affected by function loss of OsFIGNL1 during meiosis, and developmental defects of microspores are caused finally. The mutant can be applied to breeding of new dominant varieties of oryza sativa hybrids. The gene OsFIGNL1 can serve as a functional gene for regulating meiosis of oryza sativa to be applied to oryza sativa heterosis creation work in future and has huge development and utilization value and broad market application prospect.

Provided is a method for producing a homozygous non-human organism from a heterozygous non-human organism, which homozygous organism can be crossed to obtain a hybrid, comprising providing a heterozygous starting organism; allowing the organism to produce SDR-0 cells through meiosis, which cells originate from second division restitution; regenerating SDR-0 organisms from the SDR-0 cells; and producing the homozygous organism from the SDR-0 organisms thus obtained. Further provided is a method for producing a hybrid, comprising crossing a first homozygous organism that is produced according to the above method with a second homozygous organism. Also provided is a homozygous non-human organism and hybrid non-human organisms obtainable by these methods. In a preferred embodiment, the organisms are plants.